Cornea, Cataract and Refractive Surgery Department, VISSUM, Alicante, Spain.
Research & Development Department, VISSUM, Alicante, Spain.
Eur J Ophthalmol. 2021 Jul;31(4):1795-1801. doi: 10.1177/1120672120944033. Epub 2020 Jul 25.
To evaluate the visual outcomes, safety, efficacy, and causes of bilensectomy for iris fixated phakic intraocular lenses (pIOLs).
This was a two center consecutive retrospective study that included 43 eyes that underwent iris-claw pIOL bilensectomy. Patients with follow up less than 4 months were excluded from the study. Uncorrected, corrected visual acuity (UCVA, CDVA), refractive outcomes, efficacy, safety (number of eyes in which the postoperative CDVA was worse than the preoperative CDVA), endothelial cell density (ECD), causes of bilensectomy, the time between the implantation of the pIOL and bilensectomy, intra and postoperative complications were analyzed.
There was a statistically significant improvement in UCVA and CDVA after surgery ( = 0.001). The efficacy index was 0.7, four eyes had a postoperative CDVA worse than the preoperative CDVA. The mean spherical equivalent 1 year after bilensectomy was -0.78 ± 1.70 D. There was a statistically significant endothelial cell loss after iris claw lens bilensectomy ( = .003). Cataract development and endothelial cell loss were the only reasons for bilensectomy. The mean time between pIOL implantation and bilensectomy was 12.2 ± 5.5 years. One patient had corneal edema 8 months after surgery and one had a retinal detachment 11 months after surgery.
Bilensectomy was successful in improving UCVA and CDVA with an acceptable refractive outcome. Significant loss of ECD was found after surgery. The results recommend a larger ACD as selection criteria when choosing to implant an Artisan lens, and a close postoperative monitoring of the endothelial cell count.
评估虹膜固定型有晶状体眼人工晶状体(pIOL)虹膜夹取出术的视力结果、安全性、有效性和原因。
这是一项在两个中心进行的连续回顾性研究,共纳入 43 只眼行虹膜夹 pIOL 虹膜切除术。将随访时间少于 4 个月的患者排除在研究之外。分析未矫正视力(UCVA、CDVA)、屈光结果、疗效(术后 CDVA 比术前差的眼数)、内皮细胞密度(ECD)、虹膜夹取出术的原因、pIOL 植入与虹膜夹取出术之间的时间、术中及术后并发症。
术后 UCVA 和 CDVA 有统计学显著改善( = 0.001)。疗效指数为 0.7,4 只眼术后 CDVA 较术前差。术后 1 年平均等效球镜度为-0.78 ± 1.70 D。虹膜夹晶状体取出术后 ECD 有统计学显著损失( =.003)。白内障发展和内皮细胞损失是虹膜夹取出术的唯一原因。pIOL 植入与虹膜夹取出术之间的平均时间为 12.2 ± 5.5 年。1 例患者术后 8 个月角膜水肿,1 例患者术后 11 个月视网膜脱离。
虹膜夹取出术可成功改善 UCVA 和 CDVA,获得可接受的屈光结果。术后发现 ECD 显著丢失。结果建议在选择植入 Artisan 晶状体时,将更大的前房深度作为选择标准,并密切监测术后内皮细胞计数。